Microvascular Abnormality in Relapsing-Remitting Multiple Sclerosis: Perfusion MR Imaging Findings in Normal-appearing White Matter

References

• 1 Dawson JW. The histology of disseminated sclerosis. Trans R Soc Edinb 1916; 108:397-399.
  Google Scholar
• 2 Fog T. On the vessel-plaque relationships in the brain in multiple sclerosis. Acta Neurol Scand 1964; 40(suppl 10):9-15.
  Google Scholar
• 3 Adams CW, Poston RN, Buk SJ. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 1989; 92:291-306.
  MedlineGoogle Scholar
• 4 Tanaka R, Iwasaki Y, Koprowski H. Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 1975; 81:467-478.
  MedlineGoogle Scholar
• 5 Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338:278-285.
  MedlineGoogle Scholar
• 6 Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci 1997; 149:1-11.
  MedlineGoogle Scholar
• 7 Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117:1311-1322.
  MedlineGoogle Scholar
• 8 Adams CW. The onset and progression of the lesion in multiple sclerosis. J Neurol Sci 1975; 25:165-182.
  MedlineGoogle Scholar
• 9 Adams CW, Poston RN, Buk SJ, Sidhu YS, Vipond H. Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 1985; 69:269-283.
  MedlineGoogle Scholar
• 10 Trotter JL, Wegescheide CL, Garvey WF, Tourtellotte WW. Studies of myelin proteins in multiple sclerosis brain tissue. Neurochem Res 1984; 9:147-152.
  MedlineGoogle Scholar
• 11 Traugott U, Reinherz EL, Raine CS. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia- positive macrophages in lesions of different ages. J Neuroimmunol 1983; 4:201-221.
  Google Scholar
• 12 Adams CW. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977; 33:15-20.
  MedlineGoogle Scholar
• 13 Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997; 41:385-391.
  MedlineGoogle Scholar
• 14 Husted CA, Goodin DS, Hugg JW, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann Neurol 1994; 36:157-165.
  MedlineGoogle Scholar
• 15 Davie CA, Barker GJ, Thompson AJ, Tofts PS, McDonald WI, Miller DH. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 63:736-742.
  MedlineGoogle Scholar
• 16 Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995; 45:478-482.
  MedlineGoogle Scholar
• 17 Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995; 196:511-515.
  Google Scholar
• 18 Ge Y, Grossman RI, Udupa JK, Babb JS, Mannon LJ, McGowan JC. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assist Tomogr 2002; 26:62-68.
  MedlineGoogle Scholar
• 19 Wakefield AJ, More LJ, Difford J, McLaughlin JE. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994; 47:129-133.
  MedlineGoogle Scholar
• 20 Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191:41-51.
  Google Scholar
• 21 Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211:791-798.
  Google Scholar
• 22 Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998; 171:1479-1486.
  MedlineGoogle Scholar
• 23 Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Albers GW. Clinical and radiological correlates of reduced cerebral blood flow measured using magnetic resonance imaging. Arch Neurol 2002; 59:233-238.
  MedlineGoogle Scholar
• 24 Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients. J Magn Reson Imaging 2000; 12:400-410.
  MedlineGoogle Scholar
• 25 Sorensen AG, Copen WA, Ostergaard L, et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999; 210:519-527.
  Google Scholar
• 26 Doege CA, Tavakolian R, Kerskens CM, et al. Perfusion and diffusion magnetic resonance imaging in human cerebral venous thrombosis. J Neurol 2001; 248:564-571.
  MedlineGoogle Scholar
• 27 Haselhorst R, Kappos L, Bilecen D, et al. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. J Magn Reson Imaging 2000; 11:495-505.
  MedlineGoogle Scholar
• 28 Young IR, Hall AS, Bryant DJ, et al. Assessment of brain perfusion with MR imaging. J Comput Assist Tomogr 1988; 12:721-727.
  MedlineGoogle Scholar
• 29 Jensen CV, Rostrup E, Blinkenberg M, Larsson HBW, Henriksen O. Relative regional cerebral blood volume in multiple sclerosis (abstr) In: Proceedings of the Society of Magnetic Resonance in Medicine and the European Society of Magnetic Resonance in Medicine and Biology. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1995; 1297.
  Google Scholar
• 30 Petrella JR, Yang Y, Richert N, et al. Dynamic contrast MR measurements of relative cerebral blood volume in enhancing multiple sclerosis lesions: comparison to nonenhancing lesions and normal appearing white matter (abstr) In: Proceedings of the Fifth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1997; 646.
  Google Scholar
• 31 Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-231.
  MedlineGoogle Scholar
• 32 Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46:907-911.
  Google Scholar
• 33 Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994; 193:637-641.
  Google Scholar
• 34 Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. II. Experimental comparison and preliminary results. Magn Reson Med 1996; 36:726-736.
  Google Scholar
• 35 Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. I. Mathematical approach and statistical analysis. Magn Reson Med 1996; 36:715-725.
  Google Scholar
• 36 Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14:249-265.
  MedlineGoogle Scholar
• 37 Carroll TJ, Rowley HA, Haughton VM. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 2003; 227:593-600.
  Google Scholar
• 38 Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002; 224:797-803.
  Google Scholar
• 39 Schlaug G, Benfield A, Baird AE, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999; 53:1528-1537.
  MedlineGoogle Scholar
• 40 Karonen JO, Vanninen RL, Liu Y, et al. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke: ischemic penumbra predicts infarct growth. Stroke 1999; 30:1583-1590.
  MedlineGoogle Scholar
• 41 Hatazawa J, Shimosegawa E, Toyoshima H, et al. Cerebral blood volume in acute brain infarction: a combined study with dynamic susceptibility contrast MRI and 99mTc-HMPAO-SPECT. Stroke 1999; 30:800-806.
  MedlineGoogle Scholar
• 42 Kluytmans M, van der Grond J, Folkers PJ, Mali WP, Viergever MA. Differentiation of gray matter and white matter perfusion in patients with unilateral internal carotid artery occlusion. J Magn Reson Imaging 1998; 8:767-774.
  MedlineGoogle Scholar
• 43 Putnam TJ. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch Neurol Neuropsychol 1935; 32:1298-1321.
  Google Scholar
• 44 Grandin CB, Duprez TP, Smith AM, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? comparative study between relative and quantitative measurements. Radiology 2002; 223:361-370.
  Google Scholar
• 45 Sorensen AG, Reimer P. Cerebral perfusion imaging principles and current applications New York, NY: Thieme, 2000.
  Google Scholar
• 46 Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979; 41:81-91.
  MedlineGoogle Scholar
• 47 Lightman S, McDonald WI, Bird AC, et al. Retinal venous sheathing in optic neuritis: its significance for the pathogenesis of multiple sclerosis. Brain 1987; 110:405-414.
  MedlineGoogle Scholar
• 48 Arnold AC, Pepose JS, Hepler RS, Foos RY. Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics. Ophthalmology 1984; 91:255-262.
  Google Scholar
• 49 Tan IL, van Schijndel RA, Pouwels PJ, et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000; 21:1039-1042.
  MedlineGoogle Scholar
• 50 Putnam TJ. The pathogenesis of multiple sclerosis: a possible vascular factor. N Engl J Med 1933; 209:786-790.
  Google Scholar
• 51 Graham EM, Stanford MR, Sanders MD, Kasp E, Dumonde DC. A point prevalence study of 150 patients with idiopathic retinal vasculitis. I. Diagnostic value of ophthalmological features. Br J Ophthalmol 1989; 73:714-721.
  Google Scholar
• 52 Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23:339-346.
  MedlineGoogle Scholar
• 53 Jenkins HG, Ikeda H. Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J Neurol Sci 1992; 108:99-104.
  MedlineGoogle Scholar
• 54 Lycke J, Wikkelso C, Bergh AC, Jacobsson L, Andersen O. Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime. Eur Neurol 1993; 33:163-167.
  MedlineGoogle Scholar
• 55 Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001; 22:1109-1116.
  MedlineGoogle Scholar
• 56 Halliday AM, McDonald WI. Pathophysiology of demyelinating disease. Br Med Bull 1977; 33:21-27.
  MedlineGoogle Scholar
• 57 Gibson GE, Shimada M, Blass JP. Alterations in acetylcholine synthesis and cyclic nucleotides in mild cerebral hypoxia. J Neurochem 1978; 31:757-760.
  MedlineGoogle Scholar
• 58 Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 2003; 206:187-191.
  MedlineGoogle Scholar
• 59 Neuhaus O, Strasser-Fuchs S, Fazekas F, et al. Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology 2002; 59:990-997.
  MedlineGoogle Scholar
• 60 Zamvil SS, Steinman L. Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS (editorial). Neurology 2002; 59:970-971.
  MedlineGoogle Scholar
• 61 Youssef S, Stuve O, Patarroyo JC, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002; 420:78-84.
  MedlineGoogle Scholar
• 62 Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998; 43:25-31.
  MedlineGoogle Scholar
• 63 Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000; 44:466-473.
  MedlineGoogle Scholar
• 64 Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002; 33:1146-1151.
  MedlineGoogle Scholar
• 65 Axel L. Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. Radiology 1980; 137:679-686.
  Google Scholar
• 66 Adams CW. Vascular aspects of multiple sclerosis. In: Adams CW, eds. A colour atlas of multiple sclerosis and other myelin disorders. 1st ed. London, England: Wolfe, 1989; 184-188.
  Google Scholar